Jamjoom Pharmaceuticals' Attributable Net Profit, Revenue Rise

MT Newswires · 3d ago
01:31 AM EDT, 10/22/2026 (MT Newswires) -- Jamjoom Pharmaceuticals Factory Co. (SASE:4015) logged 110.2 million Saudi riyals in net profit attributable to shareholders for the third quarter, compared with 106.7 million riyals a year ago. For the three months ended Sept. 30, revenue was 354.7 million riyals versus 342.3 million riyals previously, the Tadawul-listed pharmaceutical company said Thursday.